254 related articles for article (PubMed ID: 10609659)
1. Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer.
Bemelmans AP; Horellou P; Pradier L; Brunet I; Colin P; Mallet J
Hum Gene Ther; 1999 Dec; 10(18):2987-97. PubMed ID: 10609659
[TBL] [Abstract][Full Text] [Related]
2. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease.
Kells AP; Fong DM; Dragunow M; During MJ; Young D; Connor B
Mol Ther; 2004 May; 9(5):682-8. PubMed ID: 15120329
[TBL] [Abstract][Full Text] [Related]
3. AAV1/2-mediated BDNF gene therapy in a transgenic rat model of Huntington's disease.
Connor B; Sun Y; von Hieber D; Tang SK; Jones KS; Maucksch C
Gene Ther; 2016 Mar; 23(3):283-95. PubMed ID: 26704721
[TBL] [Abstract][Full Text] [Related]
4. AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment.
Kells AP; Henry RA; Connor B
Gene Ther; 2008 Jul; 15(13):966-77. PubMed ID: 18323792
[TBL] [Abstract][Full Text] [Related]
5. Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration.
Mittoux V; Ouary S; Monville C; Lisovoski F; Poyot T; Conde F; Escartin C; Robichon R; Brouillet E; Peschanski M; Hantraye P
J Neurosci; 2002 Jun; 22(11):4478-86. PubMed ID: 12040055
[TBL] [Abstract][Full Text] [Related]
6. Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease.
Pérez-Navarro E; Canudas AM; Akerund P; Alberch J; Arenas E
J Neurochem; 2000 Nov; 75(5):2190-9. PubMed ID: 11183872
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral gene delivery of pigment epithelium-derived factor protects striatal neurons from quinolinic acid-induced excitotoxicity.
Sanagi T; Yabe T; Yamada H
J Neuropathol Exp Neurol; 2010 Mar; 69(3):224-33. PubMed ID: 20142768
[TBL] [Abstract][Full Text] [Related]
9. Donor age dependent graft development and recovery in a rat model of Huntington's disease: histological and behavioral analysis.
Schackel S; Pauly MC; Piroth T; Nikkhah G; Döbrössy MD
Behav Brain Res; 2013 Nov; 256():56-63. PubMed ID: 23916743
[TBL] [Abstract][Full Text] [Related]
10. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
[TBL] [Abstract][Full Text] [Related]
11. Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain.
Fusco FR; Zuccato C; Tartari M; Martorana A; De March Z; Giampà C; Cattaneo E; Bernardi G
Eur J Neurosci; 2003 Sep; 18(5):1093-102. PubMed ID: 12956709
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow mesenchymal stem cells can improve the motor function of a Huntington's disease rat model.
Jiang Y; Lv H; Huang S; Tan H; Zhang Y; Li H
Neurol Res; 2011 Apr; 33(3):331-7. PubMed ID: 21513650
[TBL] [Abstract][Full Text] [Related]
13. Cortical expression of brain derived neurotrophic factor and type-1 cannabinoid receptor after striatal excitotoxic lesions.
De March Z; Zuccato C; Giampà C; Patassini S; Bari M; Gasperi V; De Ceballos ML; Bernardi G; Maccarrone M; Cattaneo E; Fusco FR
Neuroscience; 2008 Mar; 152(3):734-40. PubMed ID: 18313855
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral gene transfer of GDNF, BDNF and TGF beta 2, but not CNTF, cardiotrophin-1 or IGF1, protects injured adult motoneurons after facial nerve avulsion.
Sakamoto T; Kawazoe Y; Shen JS; Takeda Y; Arakawa Y; Ogawa J; Oyanagi K; Ohashi T; Watanabe K; Inoue K; Eto Y; Watabe K
J Neurosci Res; 2003 Apr; 72(1):54-64. PubMed ID: 12645079
[TBL] [Abstract][Full Text] [Related]
15. TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.
Zhao X; Chen XQ; Han E; Hu Y; Paik P; Ding Z; Overman J; Lau AL; Shahmoradian SH; Chiu W; Thompson LM; Wu C; Mobley WC
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5655-64. PubMed ID: 27601642
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease.
Régulier E; Pereira de Almeida L; Sommer B; Aebischer P; Déglon N
Hum Gene Ther; 2002 Nov; 13(16):1981-90. PubMed ID: 12427308
[TBL] [Abstract][Full Text] [Related]
17. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
McBride JL; Ramaswamy S; Gasmi M; Bartus RT; Herzog CD; Brandon EP; Zhou L; Pitzer MR; Berry-Kravis EM; Kordower JH
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9345-50. PubMed ID: 16751280
[TBL] [Abstract][Full Text] [Related]
18. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
Ma Q; Yang J; Li T; Milner TA; Hempstead BL
Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
[TBL] [Abstract][Full Text] [Related]
19. Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: implications for timing of surgical intervention.
Watts C; Dunnett SB
J Neurosurg; 1998 Aug; 89(2):267-74. PubMed ID: 9688122
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.
Canals JM; Pineda JR; Torres-Peraza JF; Bosch M; Martín-Ibañez R; Muñoz MT; Mengod G; Ernfors P; Alberch J
J Neurosci; 2004 Sep; 24(35):7727-39. PubMed ID: 15342740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
